Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
20,962,406
-
Share change
-
-1,618,841
-
Total reported value
-
$13,416,873
-
Price per share
-
$0.64
-
Number of holders
-
44
-
Value change
-
-$1,028,939
-
Number of buys
-
8
-
Number of sells
-
17
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2023
As of 31 Mar 2023,
Aptose Biosciences Inc. - Common Shares was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,962,406 shares.
The largest 10 holders included
DRW Securities, LLC, Nantahala Capital Management, LLC, CARLSON CAPITAL L P, Sigma Planning Corp, Annandale Capital, LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Voss Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, and Formidable Asset Management, LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.